Xenon Pharmaceuticals XENE Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's prepaid & other current?
- Xenon Pharmaceuticals (XENE) reported prepaid & other current of $10.72M in Q1 2026.
- How has Xenon Pharmaceuticals's prepaid & other current changed year-over-year?
- Xenon Pharmaceuticals's prepaid & other current increased by 47.7% year-over-year, from $7.26M to $10.72M.
- What is the long-term trend for Xenon Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's prepaid & other current has grown at a 28.5% compound annual growth rate (CAGR), from $2.96M to $10.39M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.